The expression of ERCC1, DNA-PKcs protein and the relation to prognosis in non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 11, Issue 2, 2008, Pages 226-230

  Hao, Yanyan ^a   Hu, Xuejun ^a   Liu, Yunpeng ^a   Jin, Bo ^a   Wen, Hua ^a   Hou, Kezuo ^a   Kang, Jian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

DNA PKcs protein; ERCC1 protein; Lung neoplasms; Prognosis; Tissue microarray

Indexed keywords

DNA DEPENDENT PROTEIN KINASE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; PARAFFIN;

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SMOKING; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

EID: 43649102314     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2008.02.009     Document Type: Article

References (12)

1. Wachters FM, Wong LS, Timens W, et al. ERCC1, hRad51, and BRCA1 protein expression in relation to tumour response and survival of stage III/IV NSCLC patients treated with chemotherapy. Lung cancer, 2005, 50(2): 211-219.
2. Zheng Z, Chen T, Li X, et al. DNA Synthesis and Repair Genes RRM1 and ERCC1 in Lung Cancer. N Engl J Med, 2007, 356(8): 800-808.
3. Simon GR, Sharma S, Cantor A, et al. ERCC1 expression is predictor of survival in resected patients with non-small cell lung cancer. Chest, 2005, 127(3): 978-983.
4. Olaussen KA, Dunant A, Fouret P, et al. DNA repair by ERCC1 in non-small lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med, 2006, 355(10): 983-991.
5. Azuma K, Komohara Y, Sasada T, et al. Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer Sci, 2007, 98(9): 1336-1343.
6. Auckley DH, Crowell RE, Heaphy ER, et al. Reduced DNA-dependent protein kinase activity is associated with lung cancer. Carcinogenes, 2001, 22(5): 723-727.
7. Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, et al. Upregulation of DNA- dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol, 2004, 25(2): 461-468.
8. Nguyen DC, Parsa B, Close A,et al. Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas. Int J Oncol, 2003, 22(6): 1285-1290.
9. Sui JL, Sun JF, Cao ZS, et al. The abnormal expression of DNA-PKcs in malignant transformed cell line of human bronchial epithelial cells and lung cancers. Chin J of Stereology and Image Analysis, 2003, 8(3): 141-145.
10. Pan H, Zuo CT, Mao NQ, et al. Expression and clinical significance of Ku70, Ku80 and DNA-PKcs proteins in patients with stage I-II non-small cell lung cancer by tissue microarray. Chin J Lung Cancer, 2007, 10(3): 203-205.
11. Someya M, Sakata K, Matsumoto Y, et al. The association of DNA-dependent protein kinase activity with chromosomal instability and risk of cancer. Carcinogenesis, 2006, 27(1): 117-122.
12. Korabiowska M, Quentin T, Schlott T, et al. Down-regulation of Ku70 and Ku 80 mRNA expression in transitional cell carcinomas of the urinary bladder related to tumor progression. World J Urol, 2004, 22(6): 431-440.